Document Detail

The effects of rate and rhythm control on blood pressure and antihypertensive drug usage in patients with atrial fibrillation and hypertension enrolled in the AFFIRM trial.
MedLine Citation:
PMID:  20455988     Owner:  NLM     Status:  In-Process    
INTRODUCTION: Atrial fibrillation (AF) has been shown to be associated with activation of the renin-angiotensin-aldosterone system, endothelial dysfunction, and increased sympathetic activity, all of which could lead to hypertension (HTN). While the effects of HTN on AF incidence and arrhythmogenesis have been reported, the long-term effects of AF on blood pressure (BP) remain unknown. We hypothesized that a rate control strategy is associated with an increase in BP and/or antihypertensive drug therapy when compared with a rhythm control strategy in patients with a history of AF and HTN.
METHODS AND RESULTS: Using the intention to treat method, BP readings and the number of antihypertensive medication categories were analyzed over the first year of follow-up in patients with AF and HTN enrolled in the AFFIRM trial. No clinically significant changes in BP occurred. Medication data were available in 2,876 patients. In the rate control group, 27.8% of patients required a net increase in the number of antihypertensive medications when compared to 18.3% in the rhythm control group (P < 0.001). Furthermore, 27.1% of patients in the rate control group had a net decrease in the number of antihypertensive medications when compared with 41.7% in the rhythm control group (P < 0.001).
CONCLUSIONS: Our findings suggest that AF could be contributing to BP elevation in patients with a history of HTN and that a rhythm control strategy might result in a decrease in BP in these patients. This hypothesis however, requires future testing.
Syed O Masood; Stephen L Wasmund; Nazem W Akoum; Marlene J Egger; Tzung Hsiai; Mohamed H Hamdan
Related Documents :
12030868 - Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals.
18174208 - Cardiac injury after percutaneous catheter ablation for atrial fibrillation.
15244388 - The increasing need for anticoagulant therapy to prevent stroke in patients with atrial...
14661168 - Comparison of p-wave duration and dispersion in patients aged > or =65 years with those...
12358158 - Absorption kinetics of paracetamol are not influenced by high anxiety levels in preoper...
25229018 - Comparison of growth hormone treatment in patients with idiopathic short stature and id...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Journal of cardiovascular electrophysiology     Volume:  21     ISSN:  1540-8167     ISO Abbreviation:  J. Cardiovasc. Electrophysiol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9010756     Medline TA:  J Cardiovasc Electrophysiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1094-8     Citation Subset:  IM    
Copyright Information:
© 2010 Wiley Periodicals, Inc.
Division of Cardiology, University of Utah, Salt Lake City, Utah, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Contact force sensing: a speedometer for a lost driver.
Next Document:  J-wave disappearance immediately after an episode of ventricular fibrillation in a patient with resu...